Metabolic and urinary risk factors associated with Randall's papillary plaques
- PMID: 10954308
- DOI: 10.1089/end.2000.14.507
Metabolic and urinary risk factors associated with Randall's papillary plaques
Abstract
Background and purpose: Increasing evidence suggests that Randall's plaques contribute to the pathogenesis of urinary stone formation. The purpose of our study was to evaluate the urinary risk factors of stone patients who underwent endoscopic mapping of their calices for Randall's plaques.
Patients and materials: Patients (N = 143) having endoscopic procedures to remove upper tract calculi or for other purposes underwent mapping of their calices for Randall's plaques. Plaque incidence and pattern were correlated with the stone composition and urinary risk factors found on subsequent metabolic evaluation.
Results: Papillary plaques were found more commonly in patients having calcium oxalate stones than in patients with other stone types and patients without a history of stones. Papillary plaque incidence and pattern did not correlate with any specific urinary risk factor; however, patients with plaques tended to exhibit a higher incidence of all risk factors. Plaque severity tended to be greater in patients exhibiting hypercalciuria.
Conclusions: Randall's plaques are found most frequently in patients with calcium oxalate stones and are most important in the pathogenesis of calcium oxalate nephrolithiasis. Stone patients with papillary plaques are more likely to exhibit abnormalities in their urinary milieu than are patients without papillary plaques.
Similar articles
-
Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease.J Urol. 1997 Dec;158(6):2062-4. doi: 10.1016/s0022-5347(01)68153-9. J Urol. 1997. PMID: 9366312
-
Helper T-cell signaling and inflammatory pathway lead to formation of calcium phosphate but not calcium oxalate stones on Randall's plaques.Int J Urol. 2019 Jun;26(6):670-677. doi: 10.1111/iju.13950. Epub 2019 Mar 28. Int J Urol. 2019. PMID: 30919502
-
The role of Randall's plaques in the pathogenesis of calcium stones.J Urol. 2007 Jan;177(1):31-8. doi: 10.1016/j.juro.2006.08.088. J Urol. 2007. PMID: 17161996 Review.
-
Relationship of endoscopic lesions of the renal papilla with type of renal stone and 24 h urine analysis.BMC Urol. 2020 Apr 25;20(1):46. doi: 10.1186/s12894-020-00615-4. BMC Urol. 2020. PMID: 32334600 Free PMC article.
-
Randall's plaque as the origin of calcium oxalate kidney stones.Urolithiasis. 2015 Jan;43 Suppl 1:5-11. doi: 10.1007/s00240-014-0703-y. Epub 2014 Aug 7. Urolithiasis. 2015. PMID: 25098906 Review.
Cited by
-
Active metabolic lithiasis: A condition that requires proper evaluation and monitoring.Exp Ther Med. 2022 Oct 10;24(6):715. doi: 10.3892/etm.2022.11651. eCollection 2022 Dec. Exp Ther Med. 2022. PMID: 36349061 Free PMC article.
-
Characteristics of nanobacteria and their possible role in stone formation.Urol Res. 2003 Jun;31(2):47-54. doi: 10.1007/s00240-003-0304-7. Epub 2003 Mar 27. Urol Res. 2003. PMID: 12669155 Review.
-
Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.Eur J Med Res. 2009 Sep 1;14(9):378-92. doi: 10.1186/2047-783x-14-9-378. Eur J Med Res. 2009. PMID: 19748857 Free PMC article.
-
Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice.Urol Res. 2010 Dec;38(6):439-52. doi: 10.1007/s00240-010-0330-1. Epub 2010 Nov 10. Urol Res. 2010. PMID: 21063698 Free PMC article.
-
Pharmacology of stone disease.Adv Chronic Kidney Dis. 2009 Jan;16(1):30-8. doi: 10.1053/j.ackd.2008.10.004. Adv Chronic Kidney Dis. 2009. PMID: 19095203 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources